NIAID Banner Logo Image

Opportunistic Infections Citation List:

December 23, 2009 - January 5, 2010

Opportunistic protozoa COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])

1. Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against Cryptosporidium parvum in vitro development. Gargala G, Le Goff L, Ballet JJ, Favennec L, Stachulski AV, Rossignol JF. Antimicrob Agents Chemother. 2010 Jan 4. [Epub ahead of print]PMID: 20047919 [PubMed - as supplied by publisher]

ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

2. The efficacy of self-assembled cationic antimicrobial peptide nanoparticles againstCryptococcus neoformans for the treatment of meningitis. Wang H, Xu K, Liu L, Tan JP, Chen Y, Li Y, Fan W, Wei Z, Sheng J, Yang YY, Li L. Biomaterials. 2009 Dec 29. [Epub ahead of print]PMID: 20044131 [PubMed - as supplied by publisher]

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

3. The Antibacterial Activity of N-Pentylpantothenamide is Due to Inhibition of CoA Synthesis. Thomas J, Cronan JE. Antimicrob Agents Chemother. 2010 Jan 4. [Epub ahead of print]PMID: 20047918 [PubMed - as supplied by publisher]Related articles

4. Synthesis and antibacterial activity of benzyl-[3-(benzylamino-methyl)-cyclohexylmethyl]-amine derivatives. Kumar D, Joshi S, Rohilla RK, Roy N, Rawat DS. Bioorg Med Chem Lett. 2009 Dec 24. [Epub ahead of print]PMID: 20047831 [PubMed - as supplied by publisher]

5. Synthesis, in vitro antibacterial and antifungal evaluations of new alpha-hydroxyphosphonate and new alpha-acetoxyphosphonate derivatives of tetrazolo [1, 5-a] quinoline. Kategaonkar AH, Pokalwar RU, Sonar SS, Gawali VU, Shingate BB, Shingare MS. Eur J Med Chem. 2009 Dec 23. [Epub ahead of print]PMID: 20036039 [PubMed - as supplied by publisher]

6. A rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis. Bull, T.J., R. Linedale, J. Hinds, and J. Hermon-Taylor Gut Pathog, 2009. 1(1): p. 25; PMID[20030828]

7. Synthesis, antimalarial and antitubercular activity of acetylenic chalcones. Hans, R.H., E.M. Guantai, C. Lategan, P.J. Smith, B. Wan, S.G. Franzblau, J. Gut, P.J. Rosenthal, and K. Chibale. Bioorg Med Chem Lett, 2009; PMID[20045640]

8. Structure and Total Synthesis of Fungal Calpinactam, A New Antimycobacterial Agent. Koyama, N., S. Kojima, T. Fukuda, T. Nagamitsu, T. Yasuhara, S. Omura, and H. Tomoda. Org Lett, 2009; PMID[20030344]

9. Preclinical pharmacokinetics of KBF611, a new antituberculosis agent in mice and rabbits, and comparison with thiacetazone. Shahab, F.M., F. Kobarfard, B. Shafaghi, and S. Dadashzadeh. Xenobiotica, 2009; PMID[20038272]

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2021